Suppr超能文献

楔形切除术与节段切除术治疗老年ⅠA 期非小细胞肺癌患者的比较。

Wedge Resection Versus Segmentectomy for Older Patients With Stage IA Non-Small-Cell Lung Cancer.

机构信息

Massachusetts General Hospital, Department of Thoracic Surgery, Boston, Massachusetts.

Massachusetts General Hospital, Department of Thoracic Surgery, Boston, Massachusetts.

出版信息

J Surg Res. 2023 Mar;283:1133-1144. doi: 10.1016/j.jss.2022.10.020. Epub 2022 Dec 15.

Abstract

INTRODUCTION

Anatomic lung resection remains the standard of care for early-stage non-small-cell lung cancer (NSCLC), but wedge resection may offer similar survival in older adult patients. The objective of this study was to evaluate the survival of patients aged 80 y and older undergoing wedge resection versus segmentectomy for stage IA NSCLC using a large clinical registry.

METHODS

Patients aged 80 y and older in the National Cancer Database who underwent wedge resection or segmentectomy for cT1a-b N0 M0 NSCLC between 2004 and 2018 were identified for an analysis. Survival was assessed using multivariable Cox proportional hazards analysis, propensity-score matching, and inverse probability weighting. A subgroup analysis of patients who underwent lymph node evaluation with their wedge resection or segmentectomy was also performed.

RESULTS

Of the 2690 patients identified, 2272 (84%) underwent wedge resection and 418 (16%) underwent segmentectomy. Wedge resection was associated with worse 5-year overall survival relative to segmentectomy in multivariable-adjusted (adjusted Hazard Ratio: 1.26, [1.06-1.51], P = 0.01) and propensity score-matched analysis (49% [95% confidence interval {CI}: 42%-55%] versus 59% [95% CI: 52%-65%], P = 0.02). Among a subgroup of 1221 wedge resection and 347 segmentectomy patients who also received intraoperative lymph node evaluation, however, there were no significant differences in 5-year survival in multivariable-adjusted (adjusted Hazard Ratio: 1.12, [0.90-1.39], P = 0.31) or propensity score-matched analysis (55% [95% CI: 48%-62%] versus 61% [95% CI: 54%-68%], P = 0.10).

CONCLUSIONS

In this national analysis, there were no significant differences in survival between older adult patients with stage IA NSCLC who underwent wedge resection versus segmentectomy when a lymph node evaluation was performed.

摘要

简介

解剖性肺切除术仍然是早期非小细胞肺癌(NSCLC)的标准治疗方法,但楔形切除术在老年患者中可能提供相似的生存获益。本研究的目的是使用大型临床数据库评估 80 岁及以上患者行楔形切除术与段切除术治疗ⅠA 期 NSCLC 的生存情况。

方法

从 2004 年至 2018 年间国家癌症数据库中筛选出 80 岁及以上行楔形切除术或段切除术治疗 cT1a-bN0M0 NSCLC 的患者进行分析。使用多变量 Cox 比例风险分析、倾向评分匹配和逆概率加权法评估生存情况。还对接受楔形切除术或段切除术淋巴结评估的患者进行了亚组分析。

结果

在确定的 2690 例患者中,2272 例(84%)行楔形切除术,418 例(16%)行段切除术。多变量调整后(调整后的风险比:1.26,[1.06-1.51],P=0.01)和倾向评分匹配分析(楔形切除术组 5 年总生存率为 49%[95%置信区间:42%-55%],段切除术组为 59%[95%置信区间:52%-65%],P=0.02),楔形切除术与段切除术相比,与 5 年总生存率相关。然而,在 1221 例接受术中淋巴结评估的楔形切除术和 347 例段切除术患者的亚组中,多变量调整后(调整后的风险比:1.12,[0.90-1.39],P=0.31)或倾向评分匹配分析(楔形切除术组 5 年总生存率为 55%[95%置信区间:48%-62%],段切除术组为 61%[95%置信区间:54%-68%],P=0.10),5 年生存率无显著差异。

结论

在这项全国性分析中,当进行淋巴结评估时,行楔形切除术与段切除术的ⅠA 期老年 NSCLC 患者的生存情况无显著差异。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验